AMSTERDAM, March 15, 2013 /PRNewswire/ -- Snore much? Beware: it's one of the key signs of a disorder that may lead to serious chronic diseases, including diabetes or heart disease.
In an effort to help obstructive sleep apnea (OSA) sufferers identify and combat the disorder, Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced it will screen one million people worldwide for OSA over the next five years.
Philips' program, consistent with its stated commitment to improve access to health care and save lives, will include screening across North America, Europe and Asia. The program uses an online risk assessment on its World Sleep Day website. Individuals who have symptoms or believe they may be at-risk are encouraged to take the online risk assessment test. Upon completion, it will provide their risk level for OSA and encourage follow up with their health care provider."Obstructive sleep apnea steals health from its sufferers and put them on a path to potentially life-threatening diseases," said Brent Shafer, CEO, Philips Home Healthcare Solutions. "It is our goal to use our innovative solutions to help OSA sufferers identify and combat this very serious disorder." Obstructive sleep apnea is one of the most common sleep disorders, and affects approximately five to six percent of the adult population 1. It is characterized by a narrowing or closing of the upper airway, which hinders breathing during sleep. Sleep is often labeled as the 'third pillar of good health', along with diet and exercise. Philips research suggests that more than two-thirds of all people with sleep apnea are not diagnosed. The most common cause of obstructive sleep apnea is weight gain. Other signs and symptoms of sleep apnea include 2:
- Frequent loud snoring
- Pauses in breathing or gasping for breath
- Regularly falling asleep in situations, such as reading, watching TV or driving
- High blood pressure
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts